p53, mdm-2, and p21 waf-1 in the porokeratoses

被引:13
|
作者
Nelson, C
Cowper, S
Morgan, M
机构
[1] James A Haley Vet Hosp, Dept Dermatopathol, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33620 USA
[3] Univ Missouri, Kansas City, MO 64110 USA
关键词
p53; mdm-2; p21; porokeratoses;
D O I
10.1097/00000372-199910000-00003
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The etiology of the porokeratoses is unknown. Overexpression of the p53 tumor suppressor protein and disregulated cell cycle control have been pathogenically implicated. The p53 tumor suppressor gene product is regulated by mdm2 and both gene products influence cell cycle progression through the cyclin-dependent kinase inhibitor p21. Thirty-three cases of the various types of porokeratosis were immunohistochemically studied for p53, mdm2, and p21 proteins, Each of the cases showed increased p53 and decreased mdm2 and p21 expression within keratinocytes underlying cornoid lamella. This study confirms the previous findings of increased p53 staining and expands the potential roles of mdm2 and p21 in the pathogenesis of the porokeratoses.
引用
收藏
页码:420 / 425
页数:6
相关论文
共 50 条
  • [1] p53, p21 (WAF-1), apoptosis and differentiation in retinoblastomas
    Divan, A
    Stewart, R
    Mullaney, P
    Mesfer, S
    Karcioglu, ZA
    Dunsmore, IR
    Rennie, IG
    Lawry, J
    Parsons, MA
    Royds, JA
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 : 28 - 28
  • [2] Waf-1 (p21) and p53 polymorphisms in breast cancer
    Keshava, C
    Frye, BL
    Wolff, MS
    McCanlies, EC
    Weston, A
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (01) : 127 - 130
  • [3] Significance of P21(WAF-1)(p21) and P53 expression in renal cell carcinoma (RCC).
    Madan, S
    Grignon, D
    Sarkar, F
    Kattar, M
    Yaman, D
    Sakr, W
    Haas, G
    Crissman, J
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 443 - 443
  • [4] Significance of p53, Bcl-2 and p21(WAF-1) (p21) expression in lung carcinoma.
    Madan, SK
    Lee, PJ
    Valdivieso, M
    Sarkar, FH
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 935 - 935
  • [5] Molecular pathology of primary and metastatic ductal pancreatic lesions - Analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions
    Ruggeri, BA
    Huang, LY
    Berger, D
    Chang, H
    KleinSzanto, AJP
    Goodrow, T
    Wood, M
    Obara, T
    Heath, CW
    Lynch, H
    [J]. CANCER, 1997, 79 (04) : 700 - 716
  • [6] STATUS OF THE MDM-2 AND WAF-1 GENES IN MOUSE EPIDERMAL JB6 VARIANTS HARBORING WILD-TYPE P53 - A P53-INDEPENDENT INDUCTION OF WAF-1
    SUN, Y
    DONG, ZG
    JACKMAN, J
    HEGAMYER, G
    KIM, H
    COLBURN, NH
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (02) : 465 - 471
  • [7] Epithelial expression of p53, mdm-2 and p21 in normal lip and actinic cheilitis
    Martinez, Alejandra
    Brethauer, Ursula
    Borlando, Jaime
    Spencer, M. Loreto
    Rojas, I. Gina
    [J]. ORAL ONCOLOGY, 2008, 44 (09) : 878 - 883
  • [8] p21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression
    Kouvidou, C
    Stefanaki, K
    Dai, Y
    Tzardi, M
    Koutsoubi, K
    Darivianaki, K
    Karidi, E
    Rontogianni, D
    Zois, E
    Kakolyris, S
    Georgoulias, V
    Delides, G
    Kanavaros, P
    [J]. ANTICANCER RESEARCH, 1997, 17 (4A) : 2615 - 2619
  • [9] Waf-1 (p21) and p53 polymorphisms in breast cancer (vol 1, pg 127, 2002)
    Keshava, C
    Frye, BL
    Wolff, MS
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (10) : 1682 - 1682
  • [10] Role of p53 and its association with waf-1/p21 in oral squamous cell carcinoma (OSCC).
    Sartor, M
    TAvassoli, M
    Warnakulasuriya, S
    Partridge, M
    Johnson, NW
    [J]. JOURNAL OF DENTAL RESEARCH, 1997, 76 (05) : 1033 - 1033